Literature DB >> 20531428

Pediatrics: neuroprotective effects of erythropoietin in preterm infants.

Catherine Limperopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531428     DOI: 10.1038/nrneurol.2010.66

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.

Authors:  Kaija Mikkola; Niina Ritari; Viena Tommiska; Teija Salokorpi; Liisa Lehtonen; Outi Tammela; Leena Pääkkönen; Päivi Olsen; Marit Korkman; Vineta Fellman
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

Review 2.  Potential for protection and repair following injury to the developing brain: a role for erythropoietin?

Authors:  Augusto Sola; Tong-Chun Wen; Shannon E G Hamrick; Donna M Ferriero
Journal:  Pediatr Res       Date:  2005-04-06       Impact factor: 3.756

3.  Erythropoietin improves neurodevelopmental outcome of extremely preterm infants.

Authors:  Achim-Peter Neubauer; Wolfgang Voss; Michael Wachtendorf; Tanja Jungmann
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

4.  Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy.

Authors:  N R Newton; C H Leonard; R E Piecuch; R H Phibbs
Journal:  J Perinatol       Date:  1999-09       Impact factor: 2.521

5.  Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.

Authors:  Ryann Bierer; M Connie Peceny; Carol H Hartenberger; Robin K Ohls
Journal:  Pediatrics       Date:  2006-08-14       Impact factor: 7.124

6.  Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.

Authors:  Robin K Ohls; Richard A Ehrenkranz; Abhik Das; Anna M Dusick; Kimberly Yolton; Elaine Romano; Virginia Delaney-Black; Lu-Ann Papile; Neal P Simon; Jean J Steichen; Kimberly G Lee
Journal:  Pediatrics       Date:  2004-11       Impact factor: 7.124

7.  Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke.

Authors:  Fernando F Gonzalez; Patrick McQuillen; Dezhi Mu; Yunsil Chang; Michael Wendland; Zinaida Vexler; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

8.  Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.

Authors:  Mark S Brown; Delphine Eichorst; Brenda Lala-Black; Robin Gonzalez
Journal:  Pediatrics       Date:  2009-09-28       Impact factor: 7.124

9.  Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model.

Authors:  Sandra E Juul; Ronald J McPherson; Theodor K Bammler; Jasmine Wilkerson; Richard P Beyer; Federico M Farin
Journal:  Dev Neurosci       Date:  2007-10-25       Impact factor: 2.984

Review 10.  Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.

Authors:  Anna-Leena Sirén; Theresa Fasshauer; Claudia Bartels; Hannelore Ehrenreich
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

  10 in total
  4 in total

Review 1.  Congenital cardiac anomalies and white matter injury.

Authors:  Paul D Morton; Nobuyuki Ishibashi; Richard A Jonas; Vittorio Gallo
Journal:  Trends Neurosci       Date:  2015-05-01       Impact factor: 13.837

Review 2.  Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Sanjay M Aher
Journal:  Cochrane Database Syst Rev       Date:  2017-11-16

3.  Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Sanjay M Aher
Journal:  Cochrane Database Syst Rev       Date:  2020-02-11

4.  Testing the sensitivity of Tract-Based Spatial Statistics to simulated treatment effects in preterm neonates.

Authors:  Gareth Ball; James P Boardman; Tomoki Arichi; Nazakat Merchant; Daniel Rueckert; A David Edwards; Serena J Counsell
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.